View in EDS

sFlt-1 Is an Independent Predictor of Adverse Maternal Outcomes in Women With SARS-CoV-2 Infection and Hypertensive Disorders of Pregnancy.

Saved in:
Bibliographic Details
Title: sFlt-1 Is an Independent Predictor of Adverse Maternal Outcomes in Women With SARS-CoV-2 Infection and Hypertensive Disorders of Pregnancy.
Authors: Hernandez-Pacheco JA; Clinical Research Branch, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico.; Hospital de la Mujer, Mexico City, Mexico., Torres-Torres J; Clinical Research Branch, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico.; Hospital General de Mexico Dr. Eduardo Liceaga, Mexico City, Mexico.; Iberoamerican Research Network in Obstetrics, Gynecology and Translational Medicine, Mexico City, Mexico., Martinez-Portilla RJ; Clinical Research Branch, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico.; Iberoamerican Research Network in Obstetrics, Gynecology and Translational Medicine, Mexico City, Mexico., Solis-Paredes JM; Clinical Research Branch, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico., Estrada-Gutierrez G; Clinical Research Branch, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico., Mateu-Rogell P; Clinical Research Branch, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico.; Iberoamerican Research Network in Obstetrics, Gynecology and Translational Medicine, Mexico City, Mexico.; Centro de Investigación en Ciencias de la Salud, FCS, Universidad Anahuac México Campus Norte, Huixquilucan, Mexico., Nares-Torices MA; Clinical Research Branch, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico., Lopez-Marenco ME; Clinical Research Branch, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico., Escobedo-Segura KR; Hospital General de Mexico Dr. Eduardo Liceaga, Mexico City, Mexico., Posadas-Nava A; Hospital General de Mexico Dr. Eduardo Liceaga, Mexico City, Mexico., Villafan-Bernal JR; Iberoamerican Research Network in Obstetrics, Gynecology and Translational Medicine, Mexico City, Mexico.; Laboratory of Immunogenomics and Metabolic Diseases, Instituto Nacional de Medicina Genomica, Mexico City, Mexico., Rojas-Zepeda L; Iberoamerican Research Network in Obstetrics, Gynecology and Translational Medicine, Mexico City, Mexico.; Maternal Fetal Medicine Department, Instituto Materno Infantil del Estado de Mexico, Toluca, Mexico., Becerra-Navarro NP; Hospital de la Mujer, Mexico City, Mexico., Casillas-Barrera M; Hospital de la Mujer, Mexico City, Mexico., Pichardo-Cuevas M; Hospital de la Mujer, Mexico City, Mexico., Muñoz-Manrique C; Clinical Research Branch, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico.; Iberoamerican Research Network in Obstetrics, Gynecology and Translational Medicine, Mexico City, Mexico., Cortes-Ramirez IA; Hospital de la Mujer, Mexico City, Mexico., Espino-Y-Sosa S; Clinical Research Branch, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico.; Iberoamerican Research Network in Obstetrics, Gynecology and Translational Medicine, Mexico City, Mexico.
Source: Frontiers in medicine [Front Med (Lausanne)] 2022 May 09; Vol. 9, pp. 894633. Date of Electronic Publication: 2022 May 09 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2296-858X
DOI:10.3389/fmed.2022.894633